Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Baron

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Genes|January 10, 2018
MiRNA Influences in Neuroblast Modulation: An Introspective AnalysisVanessa Zammit, Byron Baron, Duncan Ayers
Oncology Research|June 3, 2024
5-Fluorouracil dose escalation generated desensitized colorectal cancer cells with reduced expression of protein methyltransferases and no epithelial-to-mesenchymal transition potentialKimberly Fenech, Isaac Micallef, Byron Baron
Cancer Genomics & Proteomics|March 15, 2015
Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environmentByron Baron, Takao Kitagawa, Kazuyuki Nakamura, et al.
GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW|August 1, 2022
A comparative profile of total protein and six angiogenically-active growth factors in three platelet productsScott Custo, Byron Baron, Alex Felice, et al.
Anticancer Research|October 28, 2015
Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer CellsMasayuki Tokunaga, Byron Baron, Takao Kitagawa, et al.
In Vivo (Athens, Greece)|June 25, 2018
Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer CellsTakuya Shimada, Yuta Nanimoto, Byron Baron, et al.
Scientific Reports|May 19, 2021
ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysisShajedul Islam, Takao Kitagawa, Byron Baron, et al.
Anticancer Research|April 12, 2015
Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin actionByron Baron, Yufeng Wang, Shin-Ichiro Maehara, et al.
Targeted Oncology|May 6, 2015
The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AXYufeng Wang, Yasuhiro Kuramitsu, Takao Kitagawa, et al.
Anticancer Research|June 11, 2013
Up-regulation of DDX39 in human malignant pleural mesothelioma cell lines compared to normal pleural mesothelial cellsYasuhiro Kuramitsu, Waka Tominaga, Byron Baron, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Genes|January 10, 2018
MiRNA Influences in Neuroblast Modulation: An Introspective AnalysisVanessa Zammit, Byron Baron, Duncan Ayers
Oncology Research|June 3, 2024
5-Fluorouracil dose escalation generated desensitized colorectal cancer cells with reduced expression of protein methyltransferases and no epithelial-to-mesenchymal transition potentialKimberly Fenech, Isaac Micallef, Byron Baron
Cancer Genomics & Proteomics|March 15, 2015
Isolation of a growth factor stress-induced pancreatic cancer sub-population: insight into changes due to micro-environmentByron Baron, Takao Kitagawa, Kazuyuki Nakamura, et al.
GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW|August 1, 2022
A comparative profile of total protein and six angiogenically-active growth factors in three platelet productsScott Custo, Byron Baron, Alex Felice, et al.
Anticancer Research|October 28, 2015
Active Hexose-correlated Compound Down-regulates Heat Shock Factor 1, a Transcription Factor for HSP27, in Gemcitabine-resistant Human Pancreatic Cancer CellsMasayuki Tokunaga, Byron Baron, Takao Kitagawa, et al.
In Vivo (Athens, Greece)|June 25, 2018
Enzyme-treated Asparagus Extract Down-regulates Heat Shock Protein 27 of Pancreatic Cancer CellsTakuya Shimada, Yuta Nanimoto, Byron Baron, et al.
Scientific Reports|May 19, 2021
ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysisShajedul Islam, Takao Kitagawa, Byron Baron, et al.
Anticancer Research|April 12, 2015
Resistance to gemcitabine in the pancreatic cancer cell line KLM1-R reversed by metformin actionByron Baron, Yufeng Wang, Shin-Ichiro Maehara, et al.
Targeted Oncology|May 6, 2015
The Histone Deacetylase Inhibitor Valproic Acid Sensitizes Gemcitabine-Induced Cytotoxicity in Gemcitabine-Resistant Pancreatic Cancer Cells Possibly Through Inhibition of the DNA Repair Protein Gamma-H2AXYufeng Wang, Yasuhiro Kuramitsu, Takao Kitagawa, et al.
Anticancer Research|June 11, 2013
Up-regulation of DDX39 in human malignant pleural mesothelioma cell lines compared to normal pleural mesothelial cellsYasuhiro Kuramitsu, Waka Tominaga, Byron Baron, et al.
Pageof 5